Paediatric Rheumatology Scholarship
Arthritis Australia, The Australian Paediatric Rheumatology Group of the Australian Rheumatology Association and Zoe’s Angels Inc. are offering a two (2) year scholarship to support paediatricians and paediatric trainees interested in training in paediatric rheumatology.
The scholarship will be paid within a three (3) year time frame allowing for time differences between local and overseas training. Training will be undertaken at Royal Australasian College of Physicians prospectively accredited paediatric rheumatology advanced training sites. Scholarships will only provide salary support for twenty four (24) months of the three (3) years the funds will be available.
The Scholarship will be equivalent to the salary and on-costs of the position to which they are appointed, to a maximum of A$120,000 p.a. per year up to two years.
This scholarship is now closed.
Key information for applicants
Before applying for funding, you must read the Terms and Conditions outlined below:
Key dates for applicants
|6 April||Call for applications open|
|31 May||Closing date|
|Late June||Assessment of applications and allocation of Scholarship|
|Late July||Interviews of eligible applicants|
|Early Aug||Recommendation and sign off by Arthritis Australia Board|
|Late Aug||Finalise agreements for successful applicant/s|
|2019||Scholarship to commence|
If you require any assistance in completing this form contact Ainslie Cahill, Arthritis Australia at firstname.lastname@example.org or phone: 02 9518 4441
Undated April 2018
LATE OR INCOMPLETE FORMS WILL NOT BE ACCEPTED
What is accessible design?
Find out about what accessible design is and about the Accessible Design Division.
Programs & Research
Arthritis Australia funds research and advocates to improve care, management, support and quality-of-life for people with arthritis.
10 steps for living well with arthritis
Here is our 10 steps checklist to help you live with arthritis.
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: